Obesity Clinical Trial
Official title:
Prehabilitation in Bariatric Surgery: a Randomized Controlled Clinical Trial
Obesity is a major public health problem in our region and constitutes a priority of the
Canary Islands Health Plan. Bariatric surgery is the most effective intervention in the
treatment of obesity and its complications. However, people with obesity have high surgical
risk and long-term outcomes are related to pre-surgical weight loss.
In patients currently on the bariatric surgery waiting list, a randomized controlled trial
will be performed in which two group interventions will be compared. One of the interventions
(standard), will consist of educational modules in food and exercise, combined with
cognitive-behavioral therapy. In the other, a specific training (prehabilitation) will be
added to encourage physical activity and the conditioning of inspiratory muscles.
The pre-surgical weight loss (principal outcome) will be compared between groups, as well as
the evolution of the complications of obesity, the functional status of the patients, their
physical activity, quality of life, immediate complications of surgery and days of admission.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | March 31, 2021 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - People with obesity (type II-IV), on the waiting list for bariatric surgery in the Complejo Hospitalario Universitario Materno-infantil de Las Palmas Exclusion Criteria: - any factor that, in the opinion of the researchers, limits the ability to monitor the intervention (language barrier, ...). |
Country | Name | City | State |
---|---|---|---|
Spain | Complejo Hospitalario Universitario Materno-infantil de Las Palmas | Las Palmas De Gran Canaria | Las Palmas |
Lead Sponsor | Collaborator |
---|---|
Hospital Universitario Insular Gran Canaria | Fundación MAPFRE Guanarteme |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight change | Increase (or decrease) in weight between the start of the program and the time of surgery (measured on a calibrated scale, with Maximum increments of 0.1Kg, under the same conditions, without footwear and with light clothing) | 4-6 months | |
Secondary | Body mass index | Calculated as weight (in Kg) divided by the squared height (in meters) | 4-6 months | |
Secondary | Body composition | Percentage of body fat and lean mass estimated by bioimpedance | 4-6 months | |
Secondary | Associated complications-Blood pressure | Systolic and diastolic blood pressure (in sitting position, after 5 minutes of rest, using a manual sphygmomanometer, with a cuff adapted to thebrachial circumference of the patient) | 4-6 months | |
Secondary | Associated complications-lipids | total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides (automatic methods) in mg/dl colorimetric tests) | 4-6 months | |
Secondary | Associated complications-glucose metabolism | HbA1c (HPLC standardized against DCCT-IFCC) | 4-6 months | |
Secondary | Associated complications-treatments | Number of drugs used for associated cardiovascular risk factors | 4-6 months | |
Secondary | Associated complications-liver enzymes | AST, ALT, GGT (automatic methods) | 4-6 months | |
Secondary | Adherence to the intervention | Attendance at the sessions (number of sessions attended) programmed. | 4-6 months | |
Secondary | Physical activity-steps | Registered by pedometers (number of steps/week) | 4-6 months | |
Secondary | Physical activity-self reported | International Physical Activity Program (IPAQ) questionnaire | 4-6 months | |
Secondary | Eating patterns-Adherence to Mediterranean diet | Validated Food questionnaire (simplified questionnaire of 14 questions of adherence to the diet Mediterranean diet of PREDIMED) . Higher scores indicate higher adherence | 4-6 months | |
Secondary | Eating patterns-eating disorders | Standardised questionnaire (bulimia and binge disorders of the EDI -Eating Disorder Inventory) | 4-6 months | |
Secondary | General health status | EQ-5D questionnaire (higher scores indicate better self-perceived health status) | 4-6 months | |
Secondary | Emotional state | Hospital scale of anxiety and depression (HADS) | 4-6 months | |
Secondary | Subjective evaluation of satisfaction, perceived effort and motivation | Development of a specific questionnaire with Likert type scale for the patient to score 1 to 10 each of the 3 items. | 4-6 months | |
Secondary | Functional capacity-walk test | 6-minute walk test (TM6): meters completed during the test | 4-6 months | |
Secondary | Functional capacity- grip strength | Grip test: hand grip dynamometer and the grip strength in both hands, indicating the dominant one. | 4-6 months | |
Secondary | Functional capacity-respiratory muscle strength | Maximum inspiratory pressure (PIM) and expiratory pressure (PEM) | 4-6 months | |
Secondary | Functional capacity-plethysmography | Lung volumes, VR (residual volume) and CRF (functional residual capacity) in ml | 4-6 months | |
Secondary | Functional capacity-Spirometry | Forced spirometry: Forced expiratory volume in 1 second (FEV1), Functional Vital Capacity (FVC) in ml. Tiffenau index will be calculated. Mesoespiratory flows | 4-6 months | |
Secondary | Functional capacity-sleep apnea questionnaire | Stop-bang screening questionnaire for sleep-related breathing disorders. | 4-6 months | |
Secondary | Functional capacity-sleep apnea polygraph | Home cardiorespiratory polygraphy for diagnosis of disorder | 4-6 months | |
Secondary | Surgical complications | Early post-surgical complications (<30 days) | 5-7 months after start of intervention | |
Secondary | Surgery-length of admission | Post-surgical length of stay (stratified by surgical technique). | 5-7 months after start of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |